Should consumers enjoy less legal protection if they take a generic drug instead of a brand name? The U.S. Supreme Court may answer that once and for all.
Tonight at 7 on the Philadelphia CNN-News affiliate WFMZ-TV, The American Law Journal presents "Are Generic Drug Manufacturers Getting a Free Pass?" Host Christopher Naughton welcomes plaintiffs attorney Claudine Q. Homolash of Sheller P.C., commercial litigator Terry M. Henry of Blank Rome, anesthesiologist Paul Langevin of Hahnemann University Hospital and research fellow and lecturer for Seton Hall Law’s Center for Health and Pharmaceutical Law and Policy, professor Kate Greenwood. The panel looks at U.S. Supreme Court cases (Pliva v. Mensing, the recent Mutual Pharmaceutical v. Bartlett) and beyond (Alabama’s Wyeth v. Weeks).
